Clinical Professor, Dept ObGyn, University of Connecticut Director, IVF laboratory, Center for Advanced Reproductive Services
Obstetrics & Gynecology
Dr. Claudio A. Benadiva, MD
|
|
Give Review
Dr. Claudio A. Benadiva practices Obstetrics & Gynecology. He has 13 awards "Best Doctors", "Top Doctor", "Top doctors for women", "President", "The Society for Assisted Reproductive Technology (SART) Prize Paper Award for the paper", "Excellence in Endoscopic Gynecology", "Resident Achievement", "Outstanding Resident Research Paper", "Degree with honors in Medicine", "Bunge & Born Foundation Award for the paper", "Best Doctors in America", "Fellow (FACOG)" and "Top Obstetrician and Gynecologist". Claudio Benadiva is a published doctor and has 62 publications published. The lastest was: 'Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome.'
Publications
- Ovulation rate and cycle characteristics in a subsequent clomiphene citrate cycle after stair-step protocol.
- Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches.
- Concurrent ovarian and ipsilateral tubal Ectopic pregnancies after a double embryo transfer: a case report.
- Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization.
- Dual trigger with gonadotropin-releasing hormone agonist (GnRHa) and standard dose human chorionic gonadotropin (hCG) to improve oocyte maturity rates.
- A prospective pilot study comparing fertilization and embryo development between fresh and vitrified sibling oocytes.
- Reproductive outcome of women 43Â years and beyond undergoing ART treatment with their own oocytes in two Connecticut university programs.
- Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
- Intensive luteal phase support after GnRH agonist trigger: it does help.
- Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
- A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders.
- In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle.
- Selection of first in vitro fertilization cycle stimulation protocol for good prognosis patients: gonadotropin releasing hormone antagonist versus agonist protocols.
- Endogenous gonadotropin flare following microdose leuprolide (MDL) stimulation protocol does not correlate with in vitro fertilization (IVF) outcome.
- Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of Ovarian hyperstimulation syndrome in high-risk patients and leads ...
- Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization.
- Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles.
- Ruptured Ectopic pregnancy with contralateral adnexal torsion after spontaneous conception.
- Influence of embryo quality and number of previous cycles on Pregnancy and multiple Pregnancy rates in women aged 35 to 37 years who received two or three embryos.
- A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders.
- Obstetrical complications in gestational carrier Pregnancies.
- Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
- Should Cochrane reviews be performed during the development of new concepts?
- GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS.
- In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary.
- The presence of multinucleated blastomeres in human embryos is correlated with chromosomal abnormalities.
- Aneuploidy 16 in human embryos increases significantly with maternal age.
- Management of benign Ovarian cystic teratomas: laparoscopy compared with laparotomy.
- Withholding gonadotropin administration is an effective alternative for the prevention of Ovarian hyperstimulation syndrome.
- Intracytoplasmic sperm injection overcomes previous fertilization failure with conventional in vitro fertilization.
- Septate uterus with cervical duplication: a full-term delivery after resection of a vaginal septum.
- An unusual anatomic variation of a unicornuate uterus with normal external Uterine morphology.
- Comparison of different regimens of a gonadotropin-releasing hormone analog during Ovarian stimulation for in vitro fertilization.
- Bovine serum albumin (BSA) can replace patient serum as a protein source in an in vitro fertilization (IVF) program.
- Cortisol levels in human follicular fluid.
- Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program.
- Cortisol stimulation of estradiol and progesterone secretion by human granulosa cells is independent of follicle-stimulating hormone effects.
- Ovarian response of individuals to different doses of human menopausal gonadotropin.
- Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives.
- An increased initial follicle-stimulating hormone/luteinizing hormone ratio does not affect Ovarian responses and the outcomes of in vitro fertilization.
- Collagen matrix influences the morphologic features and steroid secretion of human granulosa cells.
- Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
- In vitro fertilization versus tubal surgery: is pelvic reconstructive surgery obsolete?
- Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing Ovarian stimulation for in vitro fertilization.
- Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony.
- The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro f...
- The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study.
- Impact of leuprolide acetate on luteal phase function in women undergoing controlled Ovarian hyperstimulation and intrauterine insemination.
- GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
- Outcome of in vitro fertilization treatment in patients who electively inseminate a limited number of oocytes to avoid creating surplus human embryos for cryopreservat...
- Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled Ovarian stimulation before in vitro fertilization in poor responders.
- Ovarian hyperstimulation syndrome: a preventable syndrome?
- Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize Pregnancy success in cycles with gonadotropin-releasing hormone agonist ...
- An eye to the future.
- Predictive value of embryo grading for embryos with known outcomes.
- New algorithm for OHSS prevention.
- Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-r...
- Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to Ovarian stimulation.
- Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist.
- In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation.
- Reproductive efficiency of women over the age of 40 and the low risk of multiple Pregnancies.
Schools
University of Buenos Aires Faculty of Medicine
University Conn
Mariano Castex Hospital
University Of Connecticut School Of Med
New York Presbyterian HospitalWeill Cornell Med Center
Procedures Preformed
- Fluid Contrast Ultrasound
- Gynecologic Cancer Screening
- Hysteroscopy
- Removal of Reproductive Organs (Hysterectomy, Oophorectomy, Salpingectomy, Salpingo-Oophorectomy, Resection of Peritoneal Malignancy)
Conditions Treated
- Adrenogenital Disorders
- Ectopic Pregnancy
- Encounters for High-Risk Pregnancies
- Endometriosis
- View All
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Best Doctors
- Top Doctor
- Top doctors for women
- President
- The Society for Assisted Reproductive Technology (SART) Prize Paper Award for the paper
- Excellence in Endoscopic Gynecology
- Resident Achievement
- Outstanding Resident Research Paper
- Degree with honors in Medicine
- Bunge & Born Foundation Award for the paper
- Best Doctors in America
- Fellow (FACOG)
- Top Obstetrician and Gynecologist
Education
-
University of Buenos Aires
Hospital
-
Hartford Hospital
Helpful Reviews
Similar Doctors
|
Dr. Carolyn D. Runowicz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph A. Walsh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Winston A. Campbell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela S. Kueck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary E. Fiske, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erica D. Anspach, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ursula Steadman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack N. Blechner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Nulsen III, MD
This Doctor is OpenDoctor Recommended.
|